Navigation Links
BCASMC (B350-05) from European Collection of Cell Cultures (ECACC)

ProductsBCASMC (B350-05) from European Collection of Cell Cultures (ECACC)
Company European Collection of Cell Cultures (ECACC)
Item BCASMC (B350-05)
Price 
Description Bovine Coronary Artery Smooth Muscle Cells (BCASMC) (>500,000 cells)
Info European Collection of Cell Cultures (ECACC) European Collection of Cell Cultures (ECACC)
United Kingdom
Customer Service: +44 (0) 1980 612684
Fax Number: +44 (0) 1980 611315
Web Site: http://www.ecacc.org.uk/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. The National Collection of Pathogenic Viruses (NCPV) from European Collection of Cell Cultures (ECACC)
2. CnC (Cn402-05) from European Collection of Cell Cultures (ECACC)
3. CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)
4. CnAOSMC (Cn354-05) from European Collection of Cell Cultures (ECACC)
5. PPAEC (P302-05) from European Collection of Cell Cultures (ECACC)
6. PPASMC (P352-05) from European Collection of Cell Cultures (ECACC)
7. HER2plus Control Slides from European Collection of Cell Cultures (ECACC)
8. BBMVEC (B840-05) from European Collection of Cell Cultures (ECACC)
9. BAOSMC (B354-05) from European Collection of Cell Cultures (ECACC)
10. BPAEC (B302-05) from European Collection of Cell Cultures (ECACC)
11. BRAEC (B900-05) from European Collection of Cell Cultures (ECACC)
...
Kit contains: Bio-Rad Amplification Reagent, 2x Amplification Diluent, Streptavidin-HRP, Blocking Reagent, and Phosphate Buffered Saline....
...
... interface for data capture, recording, manipulation, ... from paper to this powerful solution ... an integrated LIMS, notary service, customer ... functions allow LABTrack to achieve in ...
Biology Products:
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. ... a biometric authentication company focused on the growing ... smart wallet, announces that it has filed provisional ... and Method. This invention highlights ... only authorizes an account, but also the user ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market ... Report: The Convergence of Commerce and Privacy" forecasts ... mobile biometric apps will be downloaded to smart ... The mobile biometrics market is projected to generate ... revenue during the seven-year forecast period.    ...
(Date:7/13/2015)... 13, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND ... and secure method to make payments.  With this ... introduced with its groundbreaking voice-direct payment patent application, ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4
... Toronto Scarborough researchers gives the best description yet of ... called Borderline Personality Disorder (BPD), and could lead to ... brain regions that process negative emotions (for example, anger ... brain regions that would normally help damp down negative ...
... in the business of trading wetlands rather than selling his ... for wetland restoration. Research from the University of Illinois recommends ... restoration sites result in more environmentally positive outcomes. ... current policies if a wetland is scheduled for development and ...
... New Zealand Crown Research Institute, will cooperate to publish the ... Volume 43, Issue 1, the journal will be part of ... it will be freely available on www.nzjforestryscience.com and ... in 1971, the New Zealand Journal of Forestry Science ...
Cached Biology News:New insights into the 'borderline personality' brain 2Trading wetlands no longer a deal with the devil 2Trading wetlands no longer a deal with the devil 3Springer to collaborate with Scion on open access journal 2
(Date:7/30/2015)... Marshall, MN (PRWEB) , ... July 31, 2015 , ... ... Ralco Enrichment Center at the Lyon County Fair to be held August 5-9 in ... more about where their meals come from and how agriculture impacts their daily lives. ...
(Date:7/30/2015)... July 30, 2015 According to ... (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, ... Preclinical, Clinical Trial), by End Users - Global Forecast ... expected to reach USD 2,107.99 million by 2020 from ... 15.29%. Browse more than ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7